|
CCDC82 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.01680000033733E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.8141000002192E-07 |
| Normal-vs-Stage2 |
4.942200E-03 |
| Normal-vs-Stage3 |
2.443000E-04 |
| Normal-vs-Stage4 |
3.728400E-02 |
| Stage1-vs-Stage2 |
8.161800E-01 |
| Stage1-vs-Stage3 |
6.292400E-01 |
| Stage1-vs-Stage4 |
4.014200E-02 |
| Stage2-vs-Stage3 |
5.977000E-01 |
| Stage2-vs-Stage4 |
1.392370E-01 |
| Stage3-vs-Stage4 |
1.426570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.10359999974763E-07 |
| Normal-vs-AfricanAmerican |
1.716290E-02 |
| Normal-vs-Asian |
1.701720E-02 |
| Caucasian-vs-AfricanAmerican |
2.277000E-01 |
| Caucasian-vs-Asian |
7.937400E-01 |
| AfricanAmerican-vs-Asian |
4.254600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.27969999999833E-05 |
| Normal-vs-Female |
6.37449999452144E-08 |
| Male-vs-Female |
2.218000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.528500E-02 |
| Normal-vs-Age(41-60Yrs) |
7.28920000026001E-07 |
| Normal-vs-Age(61-80Yrs) |
1.79146999998991E-05 |
| Normal-vs-Age(81-100Yrs) |
7.961900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.491400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.368800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.152000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.782400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.494200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.462600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.97650000000249E-05 |
| Normal-vs-Grade 2 |
1.7727999956918E-08 |
| Normal-vs-Grade 3 |
4.17510000000343E-05 |
| Normal-vs-Grade 4 |
3.644800E-01 |
| Grade 1-vs-Grade 2 |
5.472400E-01 |
| Grade 1-vs-Grade 3 |
1.028370E-01 |
| Grade 1-vs-Grade 4 |
3.337500E-03 |
| Grade 2-vs-Grade 3 |
3.868400E-02 |
| Grade 2-vs-Grade 4 |
4.47080000000044E-05 |
| Grade 3-vs-Grade 4 |
1.260270E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.74000830305476E-12 |
| Normal-vs-ccB subtype |
2.135900E-02 |
| ccA subtype-vs-ccB subtype |
2.43939999977627E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.76050000000316E-06 |
| Normal-vs-N1 |
5.962600E-01 |
| N0-vs-N1 |
4.137900E-02 |
|
|
